Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Pivotal, Randomized Controlled Trial Comparing the Safety and Efficacy of an Automated Insulin Delivery System With the Standard of Care in Adults With Type 2 Diabetes (EMBRACE-T2D)

NCT06692153 is registered in ClinicalTrials.gov with Embecta Corp. as lead sponsor.

NCT NCT06692153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06692153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Pivotal, Randomized Controlled Trial Comparing the Safety and Efficacy of an Automated Insulin Delivery System With the Standard of Care in Adults With Type 2 Diabetes (EMBRACE-T2D)
Lead sponsor
Embecta Corp.
Phase
Not applicable
Overall status
Withdrawn
Start date
January 31, 2025
Completion date
May 31, 2026
Enrollment
0 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

t2d, t2dm, t2dm (type 2 diabetes mellitus), t2dm with inadequate glycemic control, type 2 diabetes, type 2 diabetes mellitus (t2dm), type 2 dm